Marc Nathan Wein, M.D., Ph.D.


Physician Investigator (Cl)
Endocrine Division, Mass General Research Institute
Associate Professor of Medicine
Harvard Medical School
Assistant In Medicine
Medicine-Endocrinology, Massachusetts General Hospital
Associate Member
Broad Institute
MGH Research Scholar 2024-2029
Mass General Research Institute, Massachusetts General Hospital
M.D.; Ph.D. 2009
bone resorption; core binding factor alpha 1 subunit; hyperparathyroidism secondary; osteoblasts; osteoclasts; osteogenesis; osteoporosis; osteoporotic fractures The Wein laboratory studies molecular mechanisms controlling osteocyte differentiation and function. Our research focuses on transcriptional control of sclerostin, an osteocyte-specific secreted protein that happens to be a drug target for osteoporosis. We are interested in understanding how osteocytes turn on sclerostin, and how signals that boost bone formation (parathyroid hormone, mechanical loading) regulate its expression.